A simple algorithm for the identification of clinical COPD phenotypes | JoVE Visualize

Area of Science:

Pulmonary Medicine
Clinical Epidemiology
Biostatistics

Background:

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with varying clinical trajectories.
Identifying distinct COPD patient phenotypes is crucial for targeted management and improved outcomes.
Current classification methods may not fully capture the complexity of COPD phenotypes, especially concerning comorbidities.

Purpose of the Study:

To develop and validate a simple, rule-based algorithm for assigning COPD patients to clinically relevant subgroups.
To identify key clinical variables that differentiate COPD phenotypes, considering both respiratory status and comorbidities.
To assess the clinical utility of the developed algorithm in predicting mortality and other outcomes.

Main Methods:

Cluster analysis was employed on data from 2409 COPD patients to identify distinct patient subgroups.
Classification and Regression Trees (CART) were used to create an algorithm for patient allocation to these subgroups.
The CART-based algorithm was validated using an independent cohort of 3651 patients from the 3CIA initiative.

Main Results:

Cluster analysis revealed five distinct COPD patient subgroups characterized by differences in respiratory disease severity, cardiovascular comorbidities, and diabetes.
The CART algorithm identified that different variables (e.g., FEV1, dyspnea grade, age, BMI) were important for grouping patients with isolated respiratory disease versus those with multi-morbidity.
Validation in the 3CIA cohort confirmed the algorithm's ability to identify subgroups with significantly different 3-year mortality rates (median 4% to 27%) and age at death (median 68 to 76 years).

Conclusions:

A straightforward algorithm integrating respiratory parameters and comorbidities effectively identifies clinically relevant COPD phenotypes.
This approach facilitates the stratification of COPD patients into subgroups with distinct prognoses.
The findings support the use of this algorithm for personalized medicine strategies in COPD management.